---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-157458"
form_type: "8-K"
ticker: "SRPT"
cik: "0000873303"
company_name: "Sarepta Therapeutics, Inc."
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:45:43.049672+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Sarepta increases incentive plan shares by 500,000; all director nominees elected at annual meeting

## Summary
- Board approved amendment to 2024 Employment Commencement Incentive Plan, increasing share reserve by 500,000 to 6,185,308 shares.
- At June 6 annual meeting, all four Class I director nominees (Douglas Ingram, Hans Wigzell, Kathryn Boor, Michael Chambers) were elected.
- Advisory say-on-pay proposal passed with approximately 63.6 million votes for and 9.0 million against.
- Stockholders ratified KPMG as independent auditor for 2024; approximately 77.1 million votes in favor.

## SEC filing metadata
- accession: 0001193125-24-157458
- form_type: 8-K
- ticker: SRPT
- cik: 0000873303
- company_name: Sarepta Therapeutics, Inc.
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/873303/000119312524157458/0001193125-24-157458-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/873303/000119312524157458/d810236d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-157458
- JSON: https://secwatch.observer/filing/0001193125-24-157458.json
- Plain text: https://secwatch.observer/filing/0001193125-24-157458.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.